<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Variedades - Cruso&#xE9;</provider_name><provider_url>https://crusoe.com.br/variedades</provider_url><author_name>Jo&#xE3;o Carlos Gomes</author_name><author_url>https://crusoe.com.br/variedades/author/joaoc-junior66/</author_url><title>Anvisa aprova novo medicamento para emagrecer</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="QUm8p47Xc0"&gt;&lt;a href="https://crusoe.com.br/variedades/anvisa-aprova-novo-medicamento-para-emagrecer/"&gt;Anvisa aprova novo medicamento para emagrecer&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://crusoe.com.br/variedades/anvisa-aprova-novo-medicamento-para-emagrecer/embed/#?secret=QUm8p47Xc0" width="600" height="338" title="&#x201C;Anvisa aprova novo medicamento para emagrecer&#x201D; &#x2014; Variedades - Cruso&#xE9;" data-secret="QUm8p47Xc0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://crusoe.com.br/variedades/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://cdn.crusoe.com.br/uploads/2025/06/anvisa-medicamento-emagrecer.webp</thumbnail_url><thumbnail_width>1280</thumbnail_width><thumbnail_height>720</thumbnail_height><description>No intuito de refor&#xE7;ar as medidas de tratamento contra a obesidade, a Ag&#xEA;ncia Nacional de Vigil&#xE2;ncia Sanit&#xE1;ria (Anvisa) aprovou nesta segunda-feira (9) o uso de mais um medicamento. Agora, al&#xE9;m de ser&#xA0;indicado para o controle glic&#xEA;mico de adultos com diabetes tipo 2, o Mounjaro (tirzepatida) ter&#xE1; seu uso ampliado. A decis&#xE3;o foi publicada no Di&#xE1;rio [&hellip;]</description></oembed>
